After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company’s Tumor Microenvironment Activated ...

Get the latest news and real-time alerts from Sensei Biotherapeutics, Inc. (SNSE) stock at Seeking Alpha.

A teacher, known as “Sensei” in Japan, holds a place of deep respect, much like in many cultures worldwide. The student-teacher dynamic has been a compelling theme across global cinema, but anime ...